Flabuck wrote:
Distribution doesn't matter one bit if there is no inventory to distribute. The companies had made up many doses for weeks / months awaiting final approval. That inventory is what is out there now.
In most cases the vaccine doesn't go straight from the bottling phase to the transportation phase. You also have to balance out those in need of the second shot with people awaiting the first.
A single shot and a vaccine that doesn't need the more restrictive temperature controls are going to speed things up.
The pharma companies are limited in how many doses they can make per day, with all the regulations and quality controls needed, you can't add capacity overnight or even within months.
You also have massive planning failures at the state level in many instances. They had months to get ready and many had no idea at the start and have been playing catch up for about a month.
The US has it very very good when it comes to vaccines. They have access to much much more relative to their population than almost any other country. Don't know if they paid more, twisted the arm of Pfizer and Moderna, or what. But they have lots, and are getting them into arms.
The Canadian supply sucks. Don't know why, but we must not have had the right deals made. The US is vaccinating more people every day than we have done in total, and our restriction is that we are not getting the vaccines.
Login
Register
FAQ
Search
Calendar
